Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth R Beer

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Journal of Cosmetic Dermatology|April 27, 2023
PrabotulinumtoxinA for the treatment of glabellar lines in adults, 65 years of age and older: The fourth in a series of post hoc analyses of the phase III clinical study dataSue Ellen Cox, Benjamin Ascher, Rui L Avelar, et al.
Aesthetic Surgery Journal|May 4, 2021
The Second of Two One-Year, Multicenter, Open-Label, Repeat-Dose, Phase II Safety Studies of PrabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult PatientsZ Paul Lorenc, Jeffrey M Adelglass, Rui L Avelar, et al.
Aesthetic Surgery Journal|June 30, 2021
Corrigendum to: The Second of Two One-Year, Multicenter, Open-Label, Repeat-Dose, Phase II Safety Studies of PrabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult PatientsZ Paul Lorenc, Jeffrey M Adelglass, Rui L Avelar, et al.
JAMA Dermatology|November 6, 2014
Multicenter prospective cohort study of the incidence of adverse events associated with cosmetic dermatologic procedures: lasers, energy devices, and injectable neurotoxins and fillersMurad Alam, Rohit Kakar, Michael Nodzenski, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Journal of Cosmetic Dermatology|April 27, 2023
PrabotulinumtoxinA for the treatment of glabellar lines in adults, 65 years of age and older: The fourth in a series of post hoc analyses of the phase III clinical study dataSue Ellen Cox, Benjamin Ascher, Rui L Avelar, et al.
Aesthetic Surgery Journal|May 4, 2021
The Second of Two One-Year, Multicenter, Open-Label, Repeat-Dose, Phase II Safety Studies of PrabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult PatientsZ Paul Lorenc, Jeffrey M Adelglass, Rui L Avelar, et al.
Aesthetic Surgery Journal|June 30, 2021
Corrigendum to: The Second of Two One-Year, Multicenter, Open-Label, Repeat-Dose, Phase II Safety Studies of PrabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult PatientsZ Paul Lorenc, Jeffrey M Adelglass, Rui L Avelar, et al.
JAMA Dermatology|November 6, 2014
Multicenter prospective cohort study of the incidence of adverse events associated with cosmetic dermatologic procedures: lasers, energy devices, and injectable neurotoxins and fillersMurad Alam, Rohit Kakar, Michael Nodzenski, et al.
Pageof 3